Moon G. Choi

Chuncheon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Sinus lifts in the presence of pseudoantral and mucous retention cysts.

Sinus lifts in the presence of pseudoantral and mucous retention cysts.

Journal: Journal of the Korean Association of Oral and Maxillofacial Surgeons
Published: November 14, 2021

Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.

Heat Shock Protein 90 Inhibitors AUY922, BIIB021 and SNX5422 Induce Bim-mediated Death of Thyroid Carcinoma Cells.

Journal: Anticancer research
Published: September 13, 2020

Temporomandibular joint reconstruction with costochondral graft: case series study.

Temporomandibular joint reconstruction with costochondral graft: case series study.

Journal: Journal of the Korean Association of Oral and Maxillofacial Surgeons
Published: September 08, 2020

Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.

Evodiamine in combination with histone deacetylase inhibitors has synergistic cytotoxicity in thyroid carcinoma cells.

Journal: Endocrine
Published: December 08, 2018

Older adults' willingness to share their personal and health information when adopting healthcare technology and services.

Older adults' willingness to share their personal and health information when adopting healthcare technology and services.

Journal: International journal of medical informatics
Published: October 28, 2018

Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.

Evodiamine Suppresses Survival, Proliferation, Migration and Epithelial-Mesenchymal Transition of Thyroid Carcinoma Cells.

Journal: Anticancer research
Published: October 13, 2018

Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.

Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.

Journal: Anticancer research
Published: April 05, 2018

The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.

The dipeptidyl peptidase-IV inhibitor gemigliptin alone or in combination with NVP-AUY922 has a cytotoxic activity in thyroid carcinoma cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 07, 2017

Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.

Synergistic cytotoxicity of the dipeptidyl peptidase-IV inhibitor gemigliptin with metformin in thyroid carcinoma cells.

Journal: Endocrine
Published: August 22, 2017

Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.

Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy.

Journal: Thyroid : official journal of the American Thyroid Association
Published: August 15, 2017

Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.

Cytotoxic effect of celastrol alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: May 02, 2017

Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells.

Doxorubicin has a synergistic cytotoxicity with cucurbitacin B in anaplastic thyroid carcinoma cells.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 21, 2017
Showing 1-12 of 40

Last Updated: 09/26/2026